| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |